Paper · 37726283
References254
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
1 to 20 of 254
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34794169 | Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine. | Nature | 2022 | https://conductscience.org/library/papers/34794169 | PubMed |
| 2 | 32728218 | An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma. | Nature | 2020 | https://conductscience.org/library/papers/32728218 | PubMed |
| 3 | 32591862 | A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases. | Cancer Immunol Immunother | 2020 | https://conductscience.org/library/papers/32591862 | PubMed |
| 4 | 16947019 | T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cells. | Cancer Immunol Immunother | 2007 | https://conductscience.org/library/papers/16947019 | PubMed |
| 5 | 30518847 | Structural and molecular mechanisms for the control of eukaryotic 5'-3' mRNA decay. | Nat Struct Mol Biol | 2018 | https://conductscience.org/library/papers/30518847 | PubMed |
| 6 | 29456015 | Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity. | Vaccine | 2018 | https://conductscience.org/library/papers/29456015 | PubMed |
| 7 | 33685460 | Identification of tumor antigens and immune subtypes of cholangiocarcinoma for mRNA vaccine development. | Mol Cancer | 2021 | https://conductscience.org/library/papers/33685460 | PubMed |
| 8 | 8760800 | Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. | J Exp Med | 1996 | https://conductscience.org/library/papers/8760800 | PubMed |
| 9 | 32153780 | Toll-like receptor 7/8-matured RNA-transduced dendritic cells as post-remission therapy in acute myeloid leukaemia: results of a phase I trial. | Clin Transl Immunology | 2020 | https://conductscience.org/library/papers/32153780 | PubMed |
| 10 | 23921513 | A novel, disruptive vaccination technology: self-adjuvanted RNActive(®) vaccines. | Hum Vaccin Immunother | 2013 | https://conductscience.org/library/papers/23921513 | PubMed |
| 11 | 25263094 | The ReNAissanCe of mRNA-based cancer therapy. | Expert Rev Vaccines | 2015 | https://conductscience.org/library/papers/25263094 | PubMed |
| 12 | 29567706 | Personalized vaccines for cancer immunotherapy. | Science | 2018 | https://conductscience.org/library/papers/29567706 | PubMed |
| 13 | 35339668 | Recent advances of nanodrug delivery system in the treatment of hematologic malignancies. | Semin Cancer Biol | 2022 | https://conductscience.org/library/papers/35339668 | PubMed |
| 14 | 30803823 | mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases. | Mol Ther | 2019 | https://conductscience.org/library/papers/30803823 | PubMed |
| 15 | 26321183 | mRNA: Fulfilling the Promise of Gene Therapy. | Mol Ther | 2015 | https://conductscience.org/library/papers/26321183 | PubMed |
| 16 | 30504800 | Modified VEGF-A mRNA induces sustained multifaceted microvascular response and accelerates diabetic wound healing. | Sci Rep | 2018 | https://conductscience.org/library/papers/30504800 | PubMed |
| 17 | 18797453 | Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. | Mol Ther | 2008 | https://conductscience.org/library/papers/18797453 | PubMed |
| 18 | 28527533 | Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. | J Am Coll Cardiol | 2017 | https://conductscience.org/library/papers/28527533 | PubMed |
| 19 | 35264324 | Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study. | BMJ | 2022 | https://conductscience.org/library/papers/35264324 | PubMed |
| 20 | 8903508 | The eIF-2alpha kinases and the control of protein synthesis. | FASEB J | 1996 | https://conductscience.org/library/papers/8903508 | PubMed |
papers-2026-11-12-0.1.0
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/papers/v1/37726283/references